-
Sort By
-
Newest
-
Newest
-
Oldest
Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…
It’s back: US markets down over 4%, dividends the story of the day, a deal with the devil The ASX 200 (ASX:XJO) finished another 0.8% higher, with everything but the IT, materials and utilities sectors adding to the rally. As reporting season comes to an end, dividend payments are driving daily movements with BHP Group…